Page last updated: 2024-11-06

pamatolol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

pamatolol: RN given refers to (+-)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID43150
CHEMBL ID2110710
SCHEMBL ID828220
MeSH IDM0068492

Synonyms (20)

Synonym
pamatolol
methyl n-[2-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]ethyl]carbamate
59110-35-9
(2-(4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl) ethyl)carbamic acid methyl ester
pamatololum [inn-latin]
unii-20g2s6v53l
pamatolol [inn]
pamatololum
methyl n-(4-(2-hydroxy-3-(isopropylamino)propoxy)phenethyl)carbamat
20g2s6v53l ,
methyl (+-)-4-(2-hydroxy-3-(isopropylamino)propoxy)phenethylcarbamat
SCHEMBL828220
carbamic acid, (2-(4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)ethyl)-, methyl ester, (+/-)-
methyl (+/-)-(p-(2-hydroxy-3-(isopropylamino)propoxy)phenethyl)carbamate
CHEMBL2110710
CS-6715
HY-U00019
Q15634002
DTXSID30866737
AKOS040742363

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" The drug was well absorbed in the gastro-intestinal tract and excreted in the urine, mainly in unchanged form, within 24 hrs."( Species differences in the metabolism of pamatolol, a cardioselective beta--adrenoceptor antagonist.
Borg, KO; Hoffmann, KJ; Skånberg, I, 1979
)
0.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (12.50%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]